Consistently, genomic DNA digested with the methylation-sensitive restriction enzyme HpaII and amplified with wild-type primers revealed a significant 6-fold increase in LAMP1 promoter methylation in ALL patients compared to controls (Fig. 3B). This evidence concerns the gene LAMP1 and acute lymphoblastic leukemia.